Story · Medicine & Biotech

Next-Gen Anticoagulant Lands FDA Nod for Secondary Stroke Prevention

1 outlet · first reported by MedPage Today 1d ago

Coverage, in order

  1. 1d ago
    MedPage Today indie
    Next-Gen Anticoagulant Lands FDA Nod for Secondary Stroke Prevention

    (MedPage Today) -- The FDA approved asundexian (Sunharbo) as the first factor XIa (FXIa) inhibitor for secondary stroke prevention, the agency announced on Monday. Asundexian, an oral, direct, small-molecule inhibitor of FXIa, is indicated for...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.